152 related articles for article (PubMed ID: 34636400)
1. IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
Shafer LA; Shaffer S; Witt J; Nugent Z; Bernstein CN
Inflamm Bowel Dis; 2022 Aug; 28(8):1189-1197. PubMed ID: 34636400
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
[TBL] [Abstract][Full Text] [Related]
3. Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.
Shafer LA; Walker JR; Restall G; Chhibba T; Ivekovic M; Singh H; Targownik LE; Bernstein CN
Inflamm Bowel Dis; 2019 Jan; 25(2):352-359. PubMed ID: 29992248
[TBL] [Abstract][Full Text] [Related]
4. Independent Validation of a Self-Report Version of the IBD Disability Index (IBDDI) in a Population-Based Cohort of IBD Patients.
Shafer LA; Walker JR; Chhibba T; Ivekovic M; Singh H; Targownik LE; Peyrin-Biroulet L; Gower-Rousseau C; Sarter H; Bernstein CN
Inflamm Bowel Dis; 2018 Mar; 24(4):766-774. PubMed ID: 29554260
[TBL] [Abstract][Full Text] [Related]
5. High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study.
van Gennep S; Evers SW; Rietdijk ST; Gielen ME; de Boer NKH; Gecse KB; Ponsioen CIJ; Duijvestein M; D'Haens GR; de Boer AGEM; Löwenberg M
Inflamm Bowel Dis; 2021 Feb; 27(3):352-363. PubMed ID: 32378704
[TBL] [Abstract][Full Text] [Related]
6. An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI.
Shafer LA; Sofia MA; Rubin DT; Steinhart AH; Ng SC; Reches L; Israeli E; Bernstein CN
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2524-2531. PubMed ID: 32858200
[TBL] [Abstract][Full Text] [Related]
7. Health Care Indicators of Moderate to Severe IBD and Subsequent IBD-Related Disability: A Longitudinal Study.
Shafer LA; Walker JR; Chhibba T; Targownik LE; Singh H; Ivekovic M; Bernstein CN
Inflamm Bowel Dis; 2019 Nov; 25(12):1996-2005. PubMed ID: 31087034
[TBL] [Abstract][Full Text] [Related]
8. Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries.
Holko P; Kawalec P; Sajak-Szczerba M; Avedano L; Mossakowska M
Inflamm Bowel Dis; 2023 May; 29(5):752-762. PubMed ID: 35792501
[TBL] [Abstract][Full Text] [Related]
9. Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.
Zand A; van Deen WK; Inserra EK; Hall L; Kane E; Centeno A; Choi JM; Ha CY; Esrailian E; DʼHaens GR; Hommes DW
Inflamm Bowel Dis; 2015 Jul; 21(7):1623-30. PubMed ID: 26070004
[TBL] [Abstract][Full Text] [Related]
10. The employee absenteeism costs of inflammatory bowel disease: evidence from US National Survey Data.
Gunnarsson C; Chen J; Rizzo JA; Ladapo JA; Naim A; Lofland JH
J Occup Environ Med; 2013 Apr; 55(4):393-401. PubMed ID: 23232289
[TBL] [Abstract][Full Text] [Related]
11. Societal burden of cluster headache in the United States: a descriptive economic analysis.
Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
13. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.
Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D
Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease-related economic costs due to presenteeism and absenteeism.
Rankala R; Mattila K; Voutilainen M; Mustonen A
Scand J Gastroenterol; 2021 Jun; 56(6):687-692. PubMed ID: 33826877
[TBL] [Abstract][Full Text] [Related]
15. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.
Mandel MD; Bálint A; Lovász BD; Gulácsi L; Strbák B; Golovics PA; Farkas K; Kürti Z; Szilágyi BK; Mohás A; Molnár T; Lakatos PL
Eur J Health Econ; 2014 May; 15 Suppl 1():S121-8. PubMed ID: 24832845
[TBL] [Abstract][Full Text] [Related]
16. Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.
Song X; Quek RG; Gandra SR; Cappell KA; Fowler R; Cong Z
BMC Health Serv Res; 2015 Jun; 15():245. PubMed ID: 26104784
[TBL] [Abstract][Full Text] [Related]
17. Annual indirect costs secondary to headache disability in Brazil.
Oliveira AB; Queiroz LP; Sampaio Rocha-Filho P; Sarmento EM; Peres MF
Cephalalgia; 2020 May; 40(6):597-605. PubMed ID: 31757169
[TBL] [Abstract][Full Text] [Related]
18. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs.
Manceur AM; Ding Z; Muser E; Obando C; Voelker J; Pilon D; Kinkead F; Lafeuille MH; Lefebvre P
J Med Econ; 2020 Oct; 23(10):1092-1101. PubMed ID: 32609019
[TBL] [Abstract][Full Text] [Related]
19. Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States.
Soliman AM; Taylor HS; Bonafede M; Nelson JK; Castelli-Haley J
Fertil Steril; 2017 May; 107(5):1181-1190.e2. PubMed ID: 28476181
[TBL] [Abstract][Full Text] [Related]
20. The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs.
Kuenzig ME; Im JHB; Coward S; Windsor JW; Kaplan GG; Murthy SK; Benchimol EI; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Jones May T; Tabatabavakili S; Jogendran R; Weinstein J; Khan R; Hazan E; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Targownik LE
J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S16-S22. PubMed ID: 37674495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
